Free Trial

Vise Technologies Inc. Buys New Position in Cardinal Health, Inc. (NYSE:CAH)

Cardinal Health logo with Medical background

Vise Technologies Inc. bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,153 shares of the company's stock, valued at approximately $255,000.

Other large investors have also recently made changes to their positions in the company. Cyrus J. Lawrence LLC bought a new position in Cardinal Health in the 4th quarter worth about $26,000. Promus Capital LLC bought a new position in Cardinal Health in the 4th quarter worth about $30,000. Bellwether Advisors LLC bought a new position in Cardinal Health in the 4th quarter worth about $32,000. Lee Danner & Bass Inc. bought a new position in Cardinal Health in the 4th quarter worth about $35,000. Finally, Itau Unibanco Holding S.A. bought a new position in Cardinal Health in the 4th quarter worth about $36,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Performance

NYSE:CAH traded up $0.47 during mid-day trading on Friday, reaching $154.46. The stock had a trading volume of 2,759,499 shares, compared to its average volume of 2,229,496. The firm has a 50 day moving average price of $141.70 and a two-hundred day moving average price of $130.26. The stock has a market capitalization of $36.87 billion, a P/E ratio of 28.82, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $156.44.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The firm had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. During the same quarter in the previous year, the company posted $2.08 earnings per share. The business's revenue was up .0% on a year-over-year basis. Research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a $0.5107 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $2.04 annualized dividend and a yield of 1.32%. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's payout ratio is presently 31.83%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Jefferies Financial Group upgraded Cardinal Health from a "hold" rating to a "buy" rating and lifted their price target for the company from $140.00 to $150.00 in a research report on Wednesday, February 5th. Robert W. Baird lifted their price target on Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a research report on Friday, May 2nd. Bank of America lifted their price target on Cardinal Health from $150.00 to $155.00 and gave the company a "buy" rating in a research report on Friday, April 11th. Citigroup reiterated a "neutral" rating on shares of Cardinal Health in a research report on Thursday, May 1st. Finally, Wall Street Zen upgraded Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 5th. Four research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $146.43.

Read Our Latest Stock Analysis on Cardinal Health

Cardinal Health Company Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Read More

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines